[1] H. Lu, C. W. Stratton, and Y.-W. Tang, “Outbreak of pneumonia of unknown etiology in Wuhan, China: The mystery and the miracle,” J. Med. Virol., vol. 92, no. 4, pp. 401–402, Apr. 2020, doi: https://doi.org/10.1002/jmv.25678.
[2] World Health Organization, “WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020,” WHO Director General, 11-Mar-2020. [Online]. Available: https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19---11-march-2020. [Accessed: 06-Dec-2020].
[3] Corona Virus Resource Center, “COVID-19 Dashboard by the Center for Systems Science and Engineering (CSSE) at Johns Hopkins University (JHU),” Johns Hopkins, 06-Dec-2020. [Online]. Available: https://coronavirus.jhu.edu/map.html. [Accessed: 06-Dec-2020].
[4] A. R. Jazieh et al., “Oncologists knowledge, attitude and practice in COVID-19 pandemic and its negative impact on them: An international study,” Ann. Oncol., vol. 31, Sep. 2020, doi: 10.1016/j.annonc.2020.08.1751.
[5] J. van de Haar et al., “Caring for patients with cancer in the COVID-19 era,” Nat. Med., vol. 26, no. 5, pp. 665–671, 2020, doi: 10.1038/s41591-020-0874-8.
[6] D. Schrag, D. L. Hershman, and E. Basch, “Oncology Practice During the COVID-19 Pandemic,” JAMA, vol. 323, no. 20, pp. 2005–2006, May 2020, doi: 10.1001/jama.2020.6236.
[7] C.-L. Bong, C. Brasher, E. Chikumba, R. McDougall, J. Mellin-Olsen, and A. Enright, “The COVID-19 Pandemic: Effects on Low- and Middle-Income Countries,” Anesth. Analg., vol. 131, no. 1, 2020.
[8] Iraqi Cancer Board, Cancer care regulations in Iraq during COVID-19 pandemic. Baghdad: Ministry of Health, 2020.
[9] A. R. Jazieh et al., “The impact of COVID-19 pandemic on cancer care: A global collaborative study,” Ann. Oncol., vol. 31, Sep. 2020, doi: 10.1016/j.annonc.2020.08.2325.
[10] A. R. Jazieh et al., “Impact of the COVID-19 Pandemic on Cancer Care: A Global Collaborative Study,” JCO Glob. Oncol., vol. 6, 2020, doi: 10.1200/GO.20.00351.
[11] S. J. Nidhamalddin, R. O. Hasan, and G. O. Abubakr, “Cancer treatment during the COVID-19 pandemic in the Kurdistan Region of northern Iraq,” Ecancermedicalscience, vol. 14, Sep. 2020, doi: 10.3332/ecancer.2020.1096.
[12] K. de Joode et al., “Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective,” Eur. J. Cancer, vol. 136, pp. 132–139, Sep. 2020, doi: 10.1016/j.ejca.2020.06.019.
[13] R. Saab et al., “Impact of the coronavirus disease 2019 (COVID‐19) pandemic on pediatric oncology care in the Middle East, North Africa, and West Asia region: A report from the Pediatric Oncology East and Mediterranean (POEM) group,” Cancer, vol. 126, no. 18, Sep. 2020, doi: 10.1002/cncr.33075.
[14] T. P. Hanna, G. A. Evans, and C. M. Booth, “Cancer, COVID-19 and the precautionary principle: prioritizing treatment during a global pandemic,” Nat. Rev. Clin. Oncol., vol. 17, no. 5, May 2020, doi: 10.1038/s41571-020-0362-6.
[15] American Society of Clinical Oncology, “A Guide to Cancer Care Delivery During the COVID-19 Pandemic,” Alexandria, May 2020.
[16] European Society for Medical Oncology, “Cancer Patient Management During the COVID-19 Pandemic,” ESMO Recommendations, 2020. [Online]. Available: https://www.esmo.org/guidelines/cancer-patient-management-during-the-covid-19-pandemic?page=1. [Accessed: 06-Dec-2020].
[17] H. O. Al‐Shamsi et al., “A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group,” Oncologist, vol. 25, no. 6, Jun. 2020, doi: 10.1634/theoncologist.2020-0213.
[18] Z. Benbrahim et al., “National approaches to managing cancer care: Responses of countries in the MENA region to COVID-19 pandemic,” Ann. Oncol., vol. 31, Sep. 2020, doi: 10.1016/j.annonc.2020.08.1801.
[19] L. C. Abu Esba, H. A. Al-Abdulkarim, A. Alrushidan, and M. Al Harbi, “Pharmacy and Therapeutics Committee Preparedness Plan for COVID-19,” Glob. J. Qual. Saf. Healthc., vol. 3, no. 2, May 2020, doi: 10.36401/JQSH-20-9.
[20] European Medicines Agency, “Availability of medicines during COVID-19 pandemic,” European Medicines Agency, 2020. [Online]. Available: https://www.ema.europa.eu/en/human-regulatory/overview/public-health-threats/coronavirus-disease-covid-19/availability-medicines-during-covid-19-pandemic. [Accessed: 19-Dec-2020].
[21] Food and Drug Administration, “Drug Shortages,” FDA, 2020. [Online]. Available: https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages. [Accessed: 19-Dec-2020].
[22] H. Bauchner, P. B. Fontanarosa, and E. H. Livingston, “Conserving Supply of Personal Protective Equipment—A Call for Ideas,” JAMA, vol. 323, no. 19, p. 1911, May 2020, doi: 10.1001/jama.2020.4770.
[23] J. M. Marron, S. Joffe, R. Jagsi, R. A. Spence, and F. J. Hlubocky, “Ethics and Resource Scarcity: ASCO Recommendations for the Oncology Community During the COVID-19 Pandemic,” J. Clin. Oncol., vol. 38, no. 19, pp. 2201–2205, Apr. 2020, doi: 10.1200/JCO.20.00960.
[24] M. L. Ranney, V. Griffeth, and A. K. Jha, “Critical Supply Shortages — The Need for Ventilators and Personal Protective Equipment during the Covid-19 Pandemic,” N. Engl. J. Med., vol. 382, no. 18, Apr. 2020, doi: 10.1056/NEJMp2006141.
[25] M. Richards, M. Anderson, P. Carter, B. L. Ebert, and E. Mossialos, “The impact of the COVID-19 pandemic on cancer care,” Nat. Cancer, vol. 1, no. 6, pp. 565–567, 2020, doi: 10.1038/s43018-020-0074-y.
[26] K. S. Saini et al., “Effect of the COVID-19 pandemic on cancer treatment and research.,” Lancet. Haematol., vol. 7, no. 6, pp. e432–e435, Jun. 2020, doi: 10.1016/S2352-3026(20)30123-X.
[27] R. S. Hoehn and A. H. Zureikat, “Cancer disparities in the COVID‐19 era,” J. Surg. Oncol., vol. 122, no. 3, Sep. 2020, doi: 10.1002/jso.26043.
[28] T. J. Royce, H. K. Sanoff, and A. Rewari, “Telemedicine for Cancer Care in the Time of COVID-19,” JAMA Oncol., vol. 6, no. 11, Nov. 2020, doi: 10.1001/jamaoncol.2020.2684.
[29] Iraqi Cancer Registry, “2018 Annual Report - Iraqi Cancer Registry,” Baghdad, 2018.
[30] Z. Bakouny et al., “COVID-19 and Cancer: Current Challenges and Perspectives,” Cancer Cell, vol. 38, no. 5, Nov. 2020, doi: 10.1016/j.ccell.2020.09.018.